Application Synthetic rna’s fatal flaws Why Traditional Approaches Aren’t Enough LESS SOLUBLE Chemical modifications can reduce concentration, bioavailability, and cellular uptake. POOR PROTEIN LOADING Bulky modifications restrict synthetic RNA from RNAi protein loading. INCREASED CYTOTOXICTY Many synthetic RNA are known to be cytotoxic, especially in large doses. NON-ENZYMATIC SYNTHESIS Costly (10x), wasteful (200 PMI/base), and inefficient (50% yield, 80% purity). We are creating a sustainable platform with targeted applications Application Therapeutics: CNS, cancer, auto-immune, ophthalmic, etc. Nanomaterials: Capsules, nanowires, photonic crustals, etc. Diagnostics: Ag, Microbiomem precisiondiagnostics, etc. Modules Gene augmentatation: ASOs, siRNA, Crispr guidesm RNAI, etc. Macromolecular: Aptamers, ribozymes, origami, “mRNA”, etc. Probes: Primers, molecular beacons,m FISH probes, etc. Platform Polymer: Length, chemical modification, & protein interfaces Methods: Synthesism monomer production, bioprocess, & scale Computaitonal: Structure prediction, Primer design, etc.